During the second wave of the pandemic, demand for PCR testing exceeded capacity and adversely affected patient management. At that time (November 2020), UK policy did not support deployment of lateral flow devices for covid. Northern Care Alliance NHS Group introduced LFD for patients needing admission through emergency departments. An LFD (SD Biosensor) was introduced in the ED by pathology. Significant improvement in patient flow and reduction in nosocomial transmissions was a testimony to its clinical utility. The alliance presented at the National Virology Cell meeting and by late December 2020, the government launched its use for all ED admissions.